skip to content
Access to new oncology drugs in Canada compared with the United States and Europe Preview this item
ClosePreview this item
Checking...

Access to new oncology drugs in Canada compared with the United States and Europe

Author: Nigel S B Rawson; Fraser Institute (Vancouver, B.C.),
Publisher: [Vancouver, British Columbia] : Fraser Institute, Beaconsfield, Quebec : Canadian Electronic Library, 2012. 2014.
Series: Fraser alert
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
Cancer is the leading cause of premature death in Canada. The numbers of new cases of breast, colorectal, ovarian, prostate, and kidney cancer, and leukemia and lymphoma have changed little over the last 20 years. Moreover, the five-year survival rates for lung and ovarian cancer have remained more or less the same over the last two decades and those for breast, colorectal, and kidney cancer and lymphoma have shown  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Nigel S B Rawson; Fraser Institute (Vancouver, B.C.),
OCLC Number: 870653066
Notes: "July 2012."
Description: 1 online resource (10 pages) : illustrations.
Series Title: Fraser alert
Responsibility: by Nigel S.B. Rawson.
More information:

Abstract:

Cancer is the leading cause of premature death in Canada. The numbers of new cases of breast, colorectal, ovarian, prostate, and kidney cancer, and leukemia and lymphoma have changed little over the last 20 years. Moreover, the five-year survival rates for lung and ovarian cancer have remained more or less the same over the last two decades and those for breast, colorectal, and kidney cancer and lymphoma have shown only modest progress. Consequently, new, better treatments are needed as soon as they can be introduced. Unfortunately, the timeliness of the review and approval of new drugs for use in Canada in comparison with other industrialized countries has been a concern to patients and physicians for many years. The number of these oncology drugs approved in Canada and the time taken for their review are examined in this report.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/870653066> # Access to new oncology drugs in Canada compared with the United States and Europe
    a schema:CreativeWork, schema:MediaObject, schema:Book ;
    library:oclcnum "870653066" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/bcc> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/pharmaceutical_policy_canada> ; # Pharmaceutical policy--Canada
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Place/canada> ; # Canada.
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_politique_gouvernementale_europe> ; # Médicaments--Politique gouvernementale--Europe
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/drug_evaluation_standards> ; # Drug Evaluation--standards
    schema:about <http://id.worldcat.org/fast/1060194> ; # Pharmaceutical policy
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_autorisation_de_mise_sur_le_marche_canada> ; # Médicaments--Autorisation de mise sur le marché--Canada
    schema:about <http://id.worldcat.org/fast/898661> ; # Drug approval
    schema:about <http://id.loc.gov/authorities/subjects/sh2008109173> ; # Pharmaceutical policy--United States
    schema:about <http://id.worldcat.org/fast/810595> ; # Antineoplastic agents
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_accessibilite_etats_unis> ; # Médicaments--Accessibilité--États-Unis
    schema:about <http://id.loc.gov/authorities/subjects/sh2009123884> ; # Drug approval--United States
    schema:about <http://dewey.info/class/616.994061/e22/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/drug_approval> ; # Drug Approval
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/antineoplastic_agents_canada> ; # Antineoplastic agents--Canada
    schema:about <http://id.worldcat.org/fast/1204155> ; # United States.
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_accessibilite_europe> ; # Médicaments--Accessibilité--Europe
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_politique_gouvernementale_canada> ; # Médicaments--Politique gouvernementale--Canada
    schema:about <http://id.worldcat.org/fast/1245064> ; # Europe.
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_accessibilite_canada> ; # Médicaments--Accessibilité--Canada
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_autorisation_de_mise_sur_le_marche_europe> ; # Médicaments--Autorisation de mise sur le marché--Europe
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_politique_gouvernementale_etats_unis> ; # Médicaments--Politique gouvernementale--États-Unis
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_autorisation_de_mise_sur_le_marche_etats_unis> ; # Médicaments--Autorisation de mise sur le marché--États-Unis
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/pharmaceutical_policy_europe> ; # Pharmaceutical policy--Europe
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/drug_approval_europe> ; # Drug approval--Europe
    schema:about <http://experiment.worldcat.org/entity/work/data/1847545984#Topic/drug_approval_canada> ; # Drug approval--Canada
    schema:about <http://id.worldcat.org/fast/1204310> ; # Canada.
    schema:bookFormat schema:EBook ;
    schema:contributor <http://viaf.org/viaf/148351313> ; # Fraser Institute (Vancouver, B.C.),
    schema:copyrightYear "2012" ;
    schema:creator <http://viaf.org/viaf/313280004> ; # Nigel S. B. Rawson
    schema:datePublished "2014" ;
    schema:description "Cancer is the leading cause of premature death in Canada. The numbers of new cases of breast, colorectal, ovarian, prostate, and kidney cancer, and leukemia and lymphoma have changed little over the last 20 years. Moreover, the five-year survival rates for lung and ovarian cancer have remained more or less the same over the last two decades and those for breast, colorectal, and kidney cancer and lymphoma have shown only modest progress. Consequently, new, better treatments are needed as soon as they can be introduced. Unfortunately, the timeliness of the review and approval of new drugs for use in Canada in comparison with other industrialized countries has been a concern to patients and physicians for many years. The number of these oncology drugs approved in Canada and the time taken for their review are examined in this report."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/1847545984> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://worldcat.org/issn/1714-6720> ; # Fraser alert,
    schema:name "Access to new oncology drugs in Canada compared with the United States and Europe"@en ;
    schema:productID "870653066" ;
    schema:url <http://www.deslibris.ca/ID/240094> ;
    schema:url <http://site.ebrary.com/id/10813039> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/870653066> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/drug_evaluation_standards> # Drug Evaluation--standards
    a schema:Intangible ;
    schema:name "Drug Evaluation--standards"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_accessibilite_canada> # Médicaments--Accessibilité--Canada
    a schema:Intangible ;
    schema:name "Médicaments--Accessibilité--Canada"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_accessibilite_etats_unis> # Médicaments--Accessibilité--États-Unis
    a schema:Intangible ;
    schema:name "Médicaments--Accessibilité--États-Unis"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_accessibilite_europe> # Médicaments--Accessibilité--Europe
    a schema:Intangible ;
    schema:name "Médicaments--Accessibilité--Europe"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_autorisation_de_mise_sur_le_marche_canada> # Médicaments--Autorisation de mise sur le marché--Canada
    a schema:Intangible ;
    schema:name "Médicaments--Autorisation de mise sur le marché--Canada"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_autorisation_de_mise_sur_le_marche_etats_unis> # Médicaments--Autorisation de mise sur le marché--États-Unis
    a schema:Intangible ;
    schema:name "Médicaments--Autorisation de mise sur le marché--États-Unis"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_autorisation_de_mise_sur_le_marche_europe> # Médicaments--Autorisation de mise sur le marché--Europe
    a schema:Intangible ;
    schema:name "Médicaments--Autorisation de mise sur le marché--Europe"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_politique_gouvernementale_canada> # Médicaments--Politique gouvernementale--Canada
    a schema:Intangible ;
    schema:name "Médicaments--Politique gouvernementale--Canada"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_politique_gouvernementale_etats_unis> # Médicaments--Politique gouvernementale--États-Unis
    a schema:Intangible ;
    schema:name "Médicaments--Politique gouvernementale--États-Unis"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/1847545984#Topic/medicaments_politique_gouvernementale_europe> # Médicaments--Politique gouvernementale--Europe
    a schema:Intangible ;
    schema:name "Médicaments--Politique gouvernementale--Europe"@fr ;
    .

<http://id.loc.gov/authorities/subjects/sh2008109173> # Pharmaceutical policy--United States
    a schema:Intangible ;
    schema:name "Pharmaceutical policy--United States"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2009123884> # Drug approval--United States
    a schema:Intangible ;
    schema:name "Drug approval--United States"@en ;
    .

<http://id.worldcat.org/fast/1060194> # Pharmaceutical policy
    a schema:Intangible ;
    schema:name "Pharmaceutical policy"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://id.worldcat.org/fast/1204310> # Canada.
    a schema:Place ;
    schema:name "Canada." ;
    .

<http://id.worldcat.org/fast/1245064> # Europe.
    a schema:Place ;
    schema:name "Europe." ;
    .

<http://id.worldcat.org/fast/810595> # Antineoplastic agents
    a schema:Intangible ;
    schema:name "Antineoplastic agents"@en ;
    .

<http://id.worldcat.org/fast/898661> # Drug approval
    a schema:Intangible ;
    schema:name "Drug approval"@en ;
    .

<http://viaf.org/viaf/148351313> # Fraser Institute (Vancouver, B.C.),
    a schema:Organization ;
    schema:name "Fraser Institute (Vancouver, B.C.)," ;
    .

<http://viaf.org/viaf/313280004> # Nigel S. B. Rawson
    a schema:Person ;
    schema:familyName "Rawson" ;
    schema:givenName "Nigel S. B." ;
    schema:name "Nigel S. B. Rawson" ;
    .

<http://worldcat.org/issn/1714-6720> # Fraser alert,
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/870653066> ; # Access to new oncology drugs in Canada compared with the United States and Europe
    schema:issn "1714-6720" ;
    schema:name "Fraser alert," ;
    .

<http://www.worldcat.org/title/-/oclc/870653066>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/870653066> ; # Access to new oncology drugs in Canada compared with the United States and Europe
    schema:dateModified "2018-01-06" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.